P. González

Epigenetics-targeted drugs: current paradigms and future challenges

Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours

Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, “window-of-opportunity” study

Predicting Short-Term Survival after Gross Total or Near Total Resection in Glioblastomas by Machine Learning-Based Radiomic Analysis of Preoperative MRI